FIELD: medicine, neurology.
SUBSTANCE: the method deals with detecting an interferon status followed by medicinal therapy. Moreover, additionally one should determine patient's body area, and at observed degree I of interferon system suppression it is necessary to prescribe "Antilympholin Kz" preparation as medicinal therapy intravenously by drops at course dosage being (0.5-0.6)g x S, where S - patient's body area, every other day, and thioctacide preparation at the dosage of 300-600 mg intravenously by drops daily at a 6-8-d-long course. In case of degrees II and III of interferon system suppression one should prescribe "Antilympholin Kz" at course dosage being 0.4-0.5 g/sq. m and 0.3 -.4 g/sq. m, as for thioctacide - it should be applied at the dosage of 600-900 mg and 900-1200 mg, correspondingly. The method enables to selectively affect the immune system efficiently due to combined prescription of an immunimodulator and a preparation that accelerates its introduction at suppressing the activity of proinflammatory cytokines that prolongs disease remission due to preventing the development of immunological disorders.
EFFECT: higher efficiency of therapy.
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING PATIENTS FOR VIRAL HEPATITIS C | 2002 |
|
RU2212248C1 |
PEPTIDE FROM THE COMPOSITION OF THE IMMUNOGLOBULIN HUMAN HEAVY CHAIN, SUITABLE FOR TREATMENT OF MULTIPLE SCLEROSIS | 2016 |
|
RU2646817C1 |
METHOD OF SKIN SARCOIDOSIS TREATMENT | 2010 |
|
RU2442588C2 |
METHOD OF TREATING MULTIPLE SCLEROSIS IN CHILDREN | 2015 |
|
RU2596792C1 |
METHOD OF TREATMENT OF SERIOUS FORM OF ACNE VULGARIS | 2007 |
|
RU2340353C1 |
METHOD FOR PREDICTION OF RESPONSE TO THERAPY WITH MULTIPLE SCLEROSIS DISEASE MODIFYING DRUGS OF THE FIRST LINE | 2023 |
|
RU2818847C1 |
ANTIVIRAL PREPARATION "AMIKSIN" AND METHOD OF ITS PREPARING | 1998 |
|
RU2141314C1 |
METHOD OF THERAPY OF REMITTENT MULTIPLE SCLEROSIS | 2012 |
|
RU2523058C2 |
METHOD OF TREATING POLYPOSIS RHINOSINUSITIS | 1998 |
|
RU2140215C1 |
METHOD OF TREATMENT OF PATIENT WITH KAPOSI'S SARCOMA IDIOPATHIC TYPE | 1998 |
|
RU2140270C1 |
Authors
Dates
2005-08-10—Published
2003-10-17—Filed